Hyaline Membrane Disease in Premature Infants: A Retrospective Study
S. Benracon *
National Reference Center for Neonatology and Nutrition, CHU Ibn Sina, Rabat, Morocco.
M. A. Redouani
National Reference Center for Neonatology and Nutrition, CHU Ibn Sina, Rabat, Morocco.
I. Ouadghiri
National Reference Center for Neonatology and Nutrition, CHU Ibn Sina, Rabat, Morocco.
A. Barkat
National Reference Center for Neonatology and Nutrition, CHU Ibn Sina, Rabat, Morocco.
*Author to whom correspondence should be addressed.
Abstract
Introduction: Hyaline membrane disease (HMD) is an anatomoclinical entity related to a quantitative or qualitative insufficiency of pulmonary surfactant.
Patients and Methods: This was a retrospective study conducted at the National Reference Center for Neonatology and Nutrition, spread over a period of one and a half years.
Results: Antenatal corticotherapy was given in only 20% of cases. Pregnancy pathology was divided between preeclampsia, gestational diabetes and gestational hypertension. 66.6% of deliveries were by caesarean section before the onset of labour. Mean gestational age was 33.9± 1.5 weeks' amenorrhea, with 10% of patients less than 30 weeks' amenorrhea of gestational age. Mean weight was 1677 ± 463 g. The very low birth weight population (birth weight< 1500) represented 46.6%. Females predominated, with a sex ratio of 1.12. Tracheal intubation with respiratory assistance was used in 66.6% of cases. 73% of neonates received exogenous surfactant, due to the extent of hypoxemia. Progression was favourable in only 26% of cases.
Conclusion: In Morocco, Hyaline membrane disease is a major cause of neonatal morbidity and mortality, requiring rapid diagnosis and early management.
Keywords: Hyaline membrane disease, Antenatal corticotherapy
How to Cite
Downloads
References
Avery ME, Mead J.Surface properties in relation to atelectasis and hyaline membrane disease. AM JDis Child. 1959;97:517–523.
Herbst A, Kallen K. Influence of mode of delivery on neonatal mortality in the second twin, at and before term. BJOG. 2008;115(12):1512-7
Malhotra D, Gopalan S, Narang A. Preterm breech delivery in a developing country.Int J Gynecol Obstet. 1994;45(1):27-34.
Wolf H, Schaap AH, Bruinse HW, Smolders-de Haas H, Van Ertbruggen I, Treffers PE. Vaginal delivery compared with cesarean section in early preterm breech delivery: A comparison of a long-term outcome. Br J Obstet Gynecol. 1999; 106(5):486-91.
Rinaldi M, Maffei G, Cella A, Guglielmi M, Popolo P, Matteo M, et al. Respiratory distress syndrome after caesarean section in late preterm infants: a 6-year cohort study. In: Early Human Development, dir. 5th International Conference on Clinical Neonatology; September 11-13, 2014; Torino, Italy. Ireland: Elsevier Ireland Ltd. 2014;61-79.
Crowley PA. Antenatal corticosteroid therapy: A meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol. 1995;173:322-35.
Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.Cochrane Database Syst Rev. 2017;3:CD004454.
Grisaru-Granovsky S, Reichman B, LernerGeva L, Boyko V, Hammerman C, Samueloff A, et al. Mortality and morbidity in preterm small-for-gestational-age infants: A population-based study.Am J Obstet Gynecol. 2012;206(2):150.e1-7. 33.
9-Lorotte-Namouni S, Clamadieu C, Jarreau PH. Détresses respiratoires du nouveau-né (en dehors des malformations et des maladies génétiques ou constitutionnelles). EMC Pédiatrie. 2004; 152-170.
Al Hazzani F, Al Alaiyan S, Hassanein J, Khadawardi E. Short term outcome of very low birth weight in a tertiary care hospital in Saudi Arabia. Ann Saudi Med. 2011;31:581–5. 34.
Horbar JD, Soll RF, Edwards WH. The Vermont Oxford Network: A community of practice. Clin Perinatol. 2010;37(1):29-47.